Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Matt Husovsky
Introduction
Matt Husovsky is a notable inventor based in Ramona, California. He has made significant contributions to the field of biotechnology, particularly in the development of anti-idiotypic antibodies. With a total of two patents to his name, Husovsky's work is paving the way for advancements in medical diagnostics and therapies.
Latest Patents
Husovsky's latest patents include "Anti-idiotypic antibodies against anti-KLK2 antibodies" and "Anti-idiotypic antibodies against anti-GPRC5D antibodies." The first patent relates to anti-idiotype antibodies that specifically bind to a KL2B413 containing protein. This innovation can be utilized in methods to detect and quantify cells expressing chimeric antigen receptors that include KL2B413. The second patent focuses on anti-idiotype antibodies that bind to a GP5B83 containing protein, which can also be used to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.
Career Highlights
Husovsky is currently employed at Janssen Biotech, Inc., where he continues to work on groundbreaking research in the field of biotechnology. His expertise and innovative mindset have contributed to the company's mission of developing advanced therapeutic solutions.
Collaborations
Some of Husovsky's coworkers include Ellen Chi and Wilson Edwards. Their collaborative efforts in research and development have further enhanced the impact of their work in the biotechnology sector.
Conclusion
Matt Husovsky's contributions to the field of biotechnology through his patents and work at Janssen Biotech, Inc. highlight his role as an influential inventor. His innovative approaches to developing anti-idiotypic antibodies are set to make a significant impact in medical diagnostics and therapies.